Chen Jian, Volpi Sara, Ali Jason M, Aresu Giuseppe, Wu Liang, Chen Zhigang, Wang Jin, Chen Bei, Yang Chenlu, Soultanis Kostis Marios, Jiang Gening, Jiang Lei
Department of Thoracic surgery, Shanghai Pulmonary Hospital, Tongji University School of Medicine, China.
Department of Cardiothoracic Surgery, The Royal Papworth Hospital, Cambridge, UK.
J Thorac Dis. 2020 Jul;12(7):3582-3590. doi: 10.21037/jtd-20-425.
Uniportal video-assisted thoracoscopic surgery (VATS) although considered less invasive than the multi-port techniques, is still an intercostal approach, resulting in intercostal nerve injury. Recently, some surgeons have tried to address this problem by attempting a subxiphoid approach. The aim of our study was to assess and compare results between intercostal and subxiphoid uniportal VATS lobectomy in terms of postoperative pain and quality of life (QoL).
Patients from January 2014 to January 2018 undergoing subxiphoid and intercostal VATS lobectomy were prospectively assessed for pain and QoL at 1, 3, and 6 months following discharge. Postoperative pain was measured using a numeric rating scale (NRS) and QoL was assessed with the EuroQoL 5-dimension questionnaire (EQ5D).
Eight hundred and thirty-three patients undergoing lobectomy were included: 373 in the intercostal VATS group and 459 in the subxiphoid group. The proportion of patients with moderate or worse clinical pain was significantly lower at 1 and 3 months after subxiphoid VATS (P<0.01) compared with intercostal VATS. QoL was significantly higher following subxiphoid VATS at these same time points (P<0.001).
Uniportal subxiphoid VATS is a safe and feasible minimally invasive approach for undertaking pulmonary lobectomy that may result in reduced postoperative pain compared to conventional VATS. There may also be earlier return of QoL. A randomized controlled trial examining this further would provide further insight into our observations.
单孔电视辅助胸腔镜手术(VATS)虽被认为比多孔技术侵入性小,但仍是一种肋间入路,会导致肋间神经损伤。最近,一些外科医生试图通过剑突下入路来解决这个问题。我们研究的目的是在术后疼痛和生活质量(QoL)方面评估并比较肋间和剑突下单孔VATS肺叶切除术的结果。
对2014年1月至2018年1月接受剑突下和肋间VATS肺叶切除术的患者在出院后1、3和6个月进行疼痛和生活质量的前瞻性评估。术后疼痛采用数字评分量表(NRS)测量,生活质量用欧洲五维健康量表(EQ5D)评估。
纳入833例行肺叶切除术的患者:肋间VATS组373例,剑突下组459例。与肋间VATS相比,剑突下VATS术后1个月和3个月中度或更严重临床疼痛患者的比例显著更低(P<0.01)。在这些相同时间点,剑突下VATS后的生活质量显著更高(P<0.001)。
单孔剑突下VATS是一种安全可行的微创肺叶切除方法,与传统VATS相比,可能会减轻术后疼痛。生活质量也可能更早恢复。进一步进行随机对照试验将为我们的观察提供更深入的见解。